Clinical Trial Update: Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation [Phase 2, Phase 3]

View source ↗

Summary

This document reports on a phase 2/phase 3 clinical trial evaluating a sirolimus-based immunosuppression regimen for liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Southern Medical University, China | Conditions: Liver Transplantation | Phase 2, Phase 3 | Status: UNKNOWN